Table 1.
Categories | All High-Risk Subjects (N=181) | Appropriate Surveillance (N = 132) | Inappropriate Surveillance (N = 49) | |
---|---|---|---|---|
Frequency Row % | Frequency Row % | Frequency Row% | p-value [2] | |
Demographics | ||||
Mean Age | 46.52 [18–79] | 45.73 (+11.8) | 48.65 (+13.8) | 0.16 |
Less than 40 years old | 51(28) | 38(75) | 13(25) | 0.07 |
40–49 years old | 49(27) | 41(84) | 8(16) | |
50 years old and above | 80(44) | 52(65) | 28(35) | |
Unknown/Missing | 1(--) | 1-- | ||
Gender | ||||
Male | 59(33) | 42(71) | 17(29) | 0.72 |
Female | 122(67) | 90(74) | 32(26) | |
Educational Level | ||||
Less than college | 55(31) | 41(75) | 14(25) | 0.86 |
At least college graduate | 124(69) | 90(73) | 34(27) | |
Unknown/Missing | 2(--) | 1-- | 1-- | |
Income | ||||
Less than $50,000 | 39(23) | 29(74) | 10(26) | 1.00 |
$50,000 or greater | 129(77) | 96(74) | 33(26) | |
Unknown/Missing | 13(--) | 7-- | 6-- | |
Health Insurance | ||||
Yes | 173(96) | 125(72) | 48(28) | 0.69 |
No | 8(4) | 7(88) | 1(12) | |
Personal History | ||||
Cancer Status | 0.003 | |||
Have had cancer | 100(55) | 82(82) | 18(18) | |
Have not had cancer | 81(45) | 50(62) | 31(38) | |
Colorectal Cancer | ||||
Have had CRC | 75(41) | 64(85) | 11(15) | 0.002 |
Have not had CRC | 106(59) | 68(64) | 38(36) | |
Adenomas | ||||
Have had adenomas | 33(18) | 28(85) | 5(15) | 0.13 |
Have not had adenomas | 148(82) | 104(70) | 44(30) | |
Perceived Colon Cancer Risk | 0.06 | |||
Higher than average risk | 145(81) | 111(77) | 34(23) | |
Average or low risk | 35(19) | 21(60) | 14(40) | |
Unknown/Missing | 1(--) | -- -- | 1(--) | |
Perceived Lifetime Colon Cancer Risk | ||||
Mean (+/− SD) | 65.48 (+/− 28.0) | 66.54 (+28.6) | 62.71 (+26.7) | 0.42 |
Family History | ||||
Amsterdam Criteria | ||||
Yes | 154(85) | 111(72) | 43(28) | 0.64 |
No | 27(15) | 21(78) | 6(22) | |
First Degree Relative (FDR) with CRC at <50 years old | ||||
Yes | 101(56) | 79(78) | 22(22) | 0.09 |
No | 80(44) | 53(66) | 27(34) | |
Mean No. of FDR with CRC | 1.21 (+/− 0.96) | 1.23 (+0.9) | 1.16 (+1.1) | 0.66 |
MMR Mutation in the Family | ||||
Yes | 103(57) | 85(83) | 18(17) | 0.001 |
No | 78(43) | 47(60) | 31(40) | |
Health Practices | ||||
Physician Visits (in 12 months) | ||||
Never | 7(4) | 5(71) | 2(29) | 0.01 |
1–6 visits | 129(71) | 87(67) | 42(33) | |
7 or more visits | 45(25) | 40(89) | 5(11) | |
Provider Primarily Responsible for Health Care | ||||
Primary Care Provider | 145(82) | 100(69) | 45(31) | <0.01 |
Specialist Provider | 24(13) | 24(100) | 0(0) | |
Other or None | 9(5) | 6(67) | 3(33) | |
Unknown/Missing | 3(--) | 2-- | 1-- | |
Cancer prevention setting | ||||
Private doctor’s office | 62(35) | 44(71) | 18(29) | 0.99 |
HMO | 19(11) | 14(74) | 5(26) | |
Community hospital | 20(11) | 15(75) | 5(25) | |
Academic hospital | 48(27) | 36(75) | 12(25) | |
Cancer center | 23(13) | 18(78) | 5(22) | |
Other | 4(2) | 3(75) | 1(25) | |
Unknown/Missing | 5(--) | 2-- | 3-- | |
Academic or cancer center | 71(39) | 54(76) | 17(24) | 0.50 |
Other | 110(61) | 78(71) | 32(29) | |
Participation with Cancer Screening Tests | ||||
Fully compliant with age-appropriate health screening | 153(85) | 109(71) | 44(29) | 0.35 |
Partially compliant with age-appropriate screening recommendations | 28(15) | 23(82) | 5(18) | |
Genetic Risk Assessment | ||||
Physician Discussed Cancer Risk | ||||
Yes | 144(80) | 110(76) | 34(24) | 0.06 |
No | 37(20) | 22(60) | 15(40) | |
Visited High-Risk Clinic | ||||
Yes | 136(76) | 109(80) | 27(20) | <0.001 |
No | 43(24) | 22(51) | 21(49) | |
Unknown/Missing | 2(--) | 1-- | 1-- | |
Genetic Testing Status | ||||
Had genetic testing | 131(72) | 110(84) | 21(16) | <0.001 |
No genetic testing | 50(28) | 22(44) | 28(56) | |
Genetic Test Result | ||||
Positive | 105(80) | 89(85) | 16(15) | 0.57 |
Indeterminate | 26(20) | 21(81) | 5(19) | |
True Negative | ---- | ---- | ---- | |
Unknown | ---- | ---- | ---- | |
Study Site | 0.34 | |||
DFCI | 76(42) | 50(66) | 26(34) | |
UM | 35(19) | 27(77) | 8(23) | |
UCSF | 62(34) | 49(79) | 13(21) | |
MGH | 8(4) | 6(75) | 2(25) |
Includes study subjects who have part or all of their colon intact, and fullfilled at least one of the following:
positive personal genetic result
Amsterdam criteria and indeterminate genetic test result
Amsterdam criteria and no genetic testing done
No personal genetic testing, but with an identified mutation in the family
Fisher’s exact test was used for categorical variables, and T-test was used for continuous variables